PPT-COMPETITIVENESS OF THE LOCAL PHARMACEUTICAL MANUFACTURING INDUSTRY IN KENYA

Author : luanne-stotts | Published Date : 2018-12-04

Price of local and imported pharmaceutical products VUGIGI S K OGAJI I AND THOITHI G N 1 PSK Symposium June 15 2016 Whitesands Hotel Mombasa Kenya

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "COMPETITIVENESS OF THE LOCAL PHARMACEUTI..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

COMPETITIVENESS OF THE LOCAL PHARMACEUTICAL MANUFACTURING INDUSTRY IN KENYA: Transcript


Price of local and imported pharmaceutical products VUGIGI S K OGAJI I AND THOITHI G N 1 PSK Symposium June 15 2016 Whitesands Hotel Mombasa Kenya. 2013/14. Suriname. The Global Competitive Report. The GCR is produced by the World Economic Forum. The report is based on the Global Competitiveness Index (GCI) . The GCI captures information on the micro and macro economic foundations of national competitiveness. . The Global pharmaceutical industry-part-2. The Framework of five forces.. Potential entrants. Substitutes. Buyers. Suppliers. Implication of the five forces. Potentials entrants “Treat of entry”. Competitive Advantage of Nations. Michael Porter. Key to high productivity is the development of leading industries able to compete and dominate sectors at the international level. . 4 self-reinforcing necessities for competitive industries referred to as the diamond model. . Guido Van den Broeck, R&D, QAD. Bengt Johansson, R&D, QAD. May 10, 2017. 2. This presentation includes forward-looking statements about QAD and its business. These statements are subject to risks and uncertainties that may cause actual results and events to differ materially.  These risks and uncertainties are detailed in QAD’s SEC filings, including the company's latest Annual Report on Form . Some New Development. I P C Meeting, Copenhagen (through VC). Zafar Mirza. 18 June 2015, Brussels. . WHO/EC Project:. . “. Improving access to medical products in developing countries through building capacity for local production and related technology transfer”. Human Capital Outlook Implications for Skills Development in the Pharmaceutical Sector. Johannesburg. May 27 2015. Disclaimer . Any views or opinions expressed herein are solely those of the author and do not necessarily represent those of any company. 2015, . Geneva. . National Strategy for Pharmaceutical Manufacturing Development in Ethiopia. developing industry to improve access. P. eople everywhere have access to the essential medicines they need; that the medicines are safe, effective, and of good quality; and that the medicines are prescribed and used rationally.. Some New Development. I P C Meeting, Copenhagen (through VC). Zafar Mirza. 18 June 2015, Brussels. . WHO/EC Project:. . “. Improving access to medical products in developing countries through building capacity for local production and related technology transfer”. the . dti’s. involvement in the State’s procurement of ARV’s . Directorate: Pharmaceuticals and Medical Devices. NATIONAL DEPARTMENT OF TRADE AND . INDUSTRY. 28 June 2017. 1. Overview of the South African Pharmaceuticals Industry . The G raduate S dation at the Faculty of Business Administration and Economics of Heinrich Heine University Duessel- dorf awards up to ten doctoral scholarships, start date: 1 st April , 2016. Th The use of composite indexes for benchmarking progress . Geneva, 21.10.2014. Other special topic and regional reports: . . The Global Information Technology Report. The . Global Enabling Trade . Report. Abida Zameer. Harrisburg University. GRAD 699 PGMT. Agenda. Introduction and Problem Statement . Methodology . Results . Discussion. Conclusions. Special . Characterstics. of the pharmaceutical industry . Enhancement . Programme. (MCEP). . Trade & Industry Portfolio Committee. 25 February 2015. Mr. Lionel October. MANUFACTURING COMPETITIVENESS ENHANCEMENT PROGRAMME (MCEP). MCEP is a key programme of IPAP which is aimed at growing the... Denis Kibira, PhD. National Coordinator . MeTA. -Uganda. CEO- DUMAIC Global Health. About . MeTA. & DUMAIC. MeTA. is a multi-stakeholder platform to improve access to health commodities.. We are a catalyst/driver for change..

Download Document

Here is the link to download the presentation.
"COMPETITIVENESS OF THE LOCAL PHARMACEUTICAL MANUFACTURING INDUSTRY IN KENYA"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents